Skip to main content
Clinical Trials/NCT02663284
NCT02663284
Completed
Not Applicable

Evaluation of Non-invasive Monitor of Physiodoloris Pain in Patients With Complex Regional Pain Syndrome Treated by Nerve Block (Prospective Monocenter Study)

Hopital Foch1 site in 1 country30 target enrollmentApril 2012

Overview

Phase
Not Applicable
Intervention
Ropivacaine 0.5%
Conditions
Complex Regional Pain Syndrome
Sponsor
Hopital Foch
Enrollment
30
Locations
1
Primary Endpoint
Evaluation of ANI before the peri-neural block
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

A French University team (M. Jeanne, MD, and M. LOGIER, Ph D) have developed a pain assessment tool based on the analysis of the variability heart rate which evaluates the Analgesia Nociception Index (ANI). This index is intended to give a quantification of pain.

The aim of the present study is to assess the validity of the ANI parameter in patients with Complex Regional Pain Syndrome treated with a nerve block (reversible pain).

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
March 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients suffering from a Complex Regional Pain Syndrome of the upper or lower limb

Exclusion Criteria

  • contra-indication of a nerve block,
  • contra-indication of the use of the pain monitor

Arms & Interventions

Perineural block

Perineural block with Ropivacaine 0.5%

Intervention: Ropivacaine 0.5%

Outcomes

Primary Outcomes

Evaluation of ANI before the peri-neural block

Time Frame: 5 minutes

ANI is recorded before each nerve block

Evaluation of pain before the peri-neural block

Time Frame: 5 minutes

Pain score is recorded before each nerve block

Secondary Outcomes

  • Evaluation of ANI after the peri-neural block(10 minutes)
  • Evaluation of pain after the peri-neural block(10 minutes)

Study Sites (1)

Loading locations...

Similar Trials